This month, Jared Brancazio takes the reins as CureSearch’s Chairman of the Board, bringing to the role a strategic vision centered on collaboration, innovation, and the importance of strong, diverse volunteer leadership. Brancazio, himself a cancer survivor, previously served as Board Treasurer.
“This is a significant moment in the history of our organization said Brancazio. “We’re truly poised to transform the way childhood cancer research is approached and prioritized, and we’re making progress every day.”
“We’re thrilled to welcome Mr. Brancazio as our new Chairman of the Board,” said Kay Koehler, CureSearch President & CEO. “His wealth of experience in both the corporate and non-profit sectors is an asset to our organization, and he innately understands the importance of relationship building and volunteer leadership in driving our mission forward.”
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation.
Dr. Stuart Siegel, who served previously as Chairman, has been named Chair Emeritus, honoring his leadership and lasting impact. In this role, he’ll continue to support CureSearch by providing historical knowledge and expertise to new board leadership and acting as an ambassador for the organization.
“Dr. Siegel helped transform us into an organization singularly focused on driving research that will impact children, now,” said Koehler. “Through it all, he inspired us with the stories of children who counted on us then, and count on us today.”
Building upon the work and successes of the last decade, Brancazio looks to create a lasting impact by creating new partnerships with like-minded organizations, expanding innovative initiatives such as the CureSearch IMPACT Series, and collaborating with academic and industry leaders.
“I’m deeply honored to have the opportunity to serve childhood cancer patients and families as the new chairman,” said Brancazio. “I look forward to leading us into the next phase of our work alongside my fellow directors, our unparalleled Scientific and Industry Advisory Councils, and our, dedicated staff.”
CureSearch directors provide outstanding executive leadership, experience, and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today. To learn more about our board, visit: curesearch.org/board-of-directors